Toxin production by Campylobacter spp.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMC 172930)

Published in Clin Microbiol Rev on July 01, 1997

Authors

T M Wassenaar1

Author Affiliations

1: Institute of Medical Microbiology and Hygiene, University of Mainz, Germany. wassen@mzdmza.zdv.uni-mainz.de

Articles citing this

Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity. Genome Res (2001) 4.09

Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect Immun (2000) 1.86

Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev (2008) 1.76

Genomic characterization of Campylobacter jejuni strain M1. PLoS One (2010) 1.44

Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface. Infect Immun (2002) 1.36

Detection and characterization of autoagglutination activity by Campylobacter jejuni. Infect Immun (2000) 1.21

Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB. Infect Immun (2008) 1.20

Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens. Infect Immun (2005) 1.08

Cytolethal distending toxin genes in Campylobacter jejuni and Campylobacter coli isolates: detection and analysis by PCR. J Clin Microbiol (1999) 1.08

Molecular characterization of invasive and noninvasive Campylobacter jejuni and Campylobacter coli isolates. J Clin Microbiol (2001) 1.05

Strain-dependent induction of epithelial cell oncosis by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal distending toxin. Microbiology (2007) 0.99

Genomic investigation into strain heterogeneity and pathogenic potential of the emerging gastrointestinal pathogen Campylobacter ureolyticus. PLoS One (2013) 0.99

Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin. Infect Immun (2007) 0.93

Characterization of cytolethal distending toxin of campylobacter species isolated from captive macaque monkeys. J Clin Microbiol (2005) 0.90

Campylobacter bacteremia: a rare and under-reported event? Eur J Microbiol Immunol (Bp) (2012) 0.87

Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells. World J Gastroenterol (2008) 0.86

Campylobacter jejuni and Campylobacter coli in children from communities in Northeastern Brazil: molecular detection and relation to nutritional status. Diagn Microbiol Infect Dis (2010) 0.83

Virulence genes and cytokine profile in systemic murine Campylobacter coli infection. Virulence (2015) 0.83

Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin. Clin Vaccine Immunol (2008) 0.83

Comparison of Campylobacter isolates from poultry and humans: association between in vitro virulence properties, biotypes, and pulsed-field gel electrophoresis clusters. Appl Environ Microbiol (2003) 0.80

Prediction of CTL epitope, in silico modeling and functional analysis of cytolethal distending toxin (CDT) protein of Campylobacter jejuni. BMC Res Notes (2014) 0.78

Application of protein purification methods for the enrichment of a cytotoxin from Campylobacter jejuni. BMC Microbiol (2012) 0.75

Detection of CDT toxin genes in Campylobacter spp. strains isolated from broiler carcasses and vegetables in São Paulo, Brazil. Braz J Microbiol (2014) 0.75

First case report of myopericarditis linked to Campylobacter coli enterocolitis. BMC Infect Dis (2017) 0.75

Cross-reactivity of outer membrane proteins of Campylobacter species with cholera toxin. Indian J Med Res (2011) 0.75

Food finds its way to a woman's heart: Campylobacter jejuni-associated myopericarditis. Glob Cardiol Sci Pract (2017) 0.75

Articles cited by this

(truncated to the top 100)

Campylobacter enteritis. N Engl J Med (1981) 7.98

Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26

Experimental Campylobacter jejuni infection in humans. J Infect Dis (1988) 7.05

Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08

Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22

Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16

Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev (1992) 5.15

Pathophysiology of Campylobacter enteritis. Microbiol Rev (1986) 4.94

Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol (1991) 4.81

Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69

Motility as an intestinal colonization factor for Campylobacter jejuni. J Gen Microbiol (1985) 3.54

Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev (1996) 3.46

Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun (1994) 3.36

Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34

A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog (1988) 3.24

The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit. J Biol Chem (1981) 3.13

Cholera-like enterotoxin produced by Campylobacter jejuni. Characterisation and clinical significance. Lancet (1983) 3.02

Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion. EMBO J (1991) 3.01

Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun (1994) 2.94

Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun (1996) 2.85

Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates. Infect Immun (1986) 2.85

Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. Infect Immun (1993) 2.63

Subunit structure of Shigella cytotoxin. J Biol Chem (1981) 2.59

Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology (1987) 2.54

Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect Immun (1987) 2.46

Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun (1992) 2.35

Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol (1996) 2.11

Adhesion to and invasion of HEp-2 cells by Campylobacter spp. Infect Immun (1989) 2.06

Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91

Investigations on the role of flagella in the colonization of infant mice with Campylobacter jejuni and attachment of Campylobacter jejuni to human epithelial cell lines. J Hyg (Lond) (1985) 1.88

Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun (1989) 1.65

Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations. Infect Immun (1985) 1.63

Iron acquisition and hemolysin production by Campylobacter jejuni. Infect Immun (1992) 1.54

Properties of crude Campylobacter jejuni heat-labile enterotoxin. Infect Immun (1984) 1.49

Pore-forming bacterial protein hemolysins (cytolysins). Crit Rev Microbiol (1991) 1.48

Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis. J Clin Microbiol (1986) 1.48

Assays of hemolytic toxins. Methods Enzymol (1994) 1.46

Systems of experimental genetics for Campylobacter species. Methods Enzymol (1994) 1.45

Recovery of injured Campylobacter jejuni cells after animal passage. Appl Environ Microbiol (1991) 1.45

Characteristics of the internalization and intracellular survival of Campylobacter jejuni in human epithelial cell cultures. Microb Pathog (1992) 1.39

Infection of adult Syrian hamsters with flagellar variants of Campylobacter jejuni. Infect Immun (1990) 1.37

Two-step processing for activation of the cytolysin/hemolysin of Vibrio cholerae O1 biotype El Tor: nucleotide sequence of the structural gene (hlyA) and characterization of the processed products. Infect Immun (1990) 1.34

Identification of Campylobacter jejuni surface proteins that bind to Eucaryotic cells in vitro. Infect Immun (1990) 1.32

Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun (1995) 1.26

Hepatotoxic activity of Campylobacter jejuni. J Med Microbiol (1990) 1.26

Toxins produced by Campylobacter jejuni and Campylobacter coli. Lancet (1984) 1.24

Genetic probing of Campylobacter jejuni for cholera toxin and Escherichia coli heat-labile enterotoxin. Lancet (1984) 1.21

Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age. Infect Immun (1989) 1.20

Demonstration of a cytotoxin from Campylobacter jejuni. J Clin Pathol (1983) 1.18

Adhesion to HeLa cells of Campylobacter jejuni and C. coli outer membrane components. Res Microbiol (1990) 1.18

Immunological relationship of the B subunits of Campylobacter jejuni and Escherichia coli heat-labile enterotoxins. Infect Immun (1985) 1.18

Molecular characterization of a Campylobacter jejuni lipoprotein with homology to periplasmic siderophore-binding proteins. J Bacteriol (1995) 1.17

Enzyme-linked immunosorbent assays for virulence properties of Campylobacter jejuni clinical isolates. J Clin Microbiol (1986) 1.17

Enterohemolysin, a new type of hemolysin produced by some strains of enteropathogenic E. coli (EPEC). Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.17

Production of a unique cytotoxin by Campylobacter jejuni. Infect Immun (1987) 1.16

An environmentally regulated pilus-like appendage involved in Campylobacter pathogenesis. Mol Microbiol (1996) 1.16

The different hemolysins of Escherichia coli. Med Microbiol Immunol (1991) 1.14

Factors that influence the interaction of Campylobacter jejuni with cultured mammalian cells. J Med Microbiol (1992) 1.13

Characterization and sequence of a 33-kDa enterohemolysin (Ehly 1)-associated protein in Escherichia coli. Gene (1993) 1.13

Enterohemolysin production is associated with a temperate bacteriophage in Escherichia coli serogroup O26 strains. J Bacteriol (1990) 1.09

Isolation of enterohemolysin (Ehly2)-associated sequences encoded on temperate phages of Escherichia coli. Gene (1993) 1.09

Enterotoxigenic Campylobacter jejuni among children in South India. Lancet (1984) 1.08

Mononuclear cell response in the liver of mice infected with hepatotoxigenic Campylobacter jejuni. J Med Microbiol (1992) 1.08

Production of cholera-like toxin by Campylobacter jejuni/coli. Lancet (1984) 1.07

Characterization of Vibrio cholerae El Tor cytolysin as an oligomerizing pore-forming toxin. Med Microbiol Immunol (1995) 1.03

Calcium-dependent intestinal chloride secretion by Vibrio parahaemolyticus thermostable direct hemolysin in a rabbit model. Gastroenterology (1995) 1.02

Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. J Infect Dis (1989) 1.01

Study of haemolytic activity of some Campylobacter spp. on blood agar plates. J Appl Bacteriol (1990) 0.98

The 16th C. L. Oakley Lecture. Virulence of Campylobacter species: a molecular genetic approach. J Med Microbiol (1995) 0.98

Production of cytolethal distending toxin (CLDT) by Campylobacter fetus subsp. fetus isolated from calves. J Vet Med Sci (1993) 0.96

Production of a Shiga-like cytotoxin by Campylobacter. Microb Pathog (1988) 0.95

Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni. J Clin Microbiol (1990) 0.95

Effect of iron concentration on toxin production in Campylobacter jejuni and Campylobacter coli. Can J Microbiol (1986) 0.95

Pathological changes in the rabbit ileal loop model caused by Campylobacter jejuni from human colitis. J Med Microbiol (1993) 0.95

Serum antibodies to heat-labile enterotoxin of Campylobacter jejuni. J Infect Dis (1985) 0.94

Culture supernatants of Campylobacter jejuni induce a secretory response in jejunal segments of adult rats. Infect Immun (1983) 0.93

Heat-labile and heat-stable haemolysins of Campylobacter jejuni. FEMS Immunol Med Microbiol (1993) 0.93

A rapid, colourimetric assay for cytotoxin activity in Campylobacter jejuni. FEMS Immunol Med Microbiol (1996) 0.93

Enterotoxigenicity and frequency of Campylobacter jejuni, C. coli and C. laridis in human and animal stool isolates from different countries. FEMS Microbiol Lett (1990) 0.92

Production of cytotoxins by Campylobacter. Lancet (1986) 0.92

Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection. Med Microbiol Immunol (1994) 0.90

Swedish isolates of Campylobacter jejuni/coli do not produce cytotonic or cytotoxic enterotoxins. Lancet (1983) 0.89

Enterotoxigenicity of chicken isolates of Campylobacter jejuni in ligated ileal loops of rats. J Med Microbiol (1988) 0.89

Purification of Campylobacter jejuni enterotoxin. Lancet (1984) 0.89

Incidence of toxigenic Campylobacter strains in South Africa. J Clin Microbiol (1991) 0.88

Campylobacter jejuni chromosomal sequences that hybridize to Vibrio cholerae and Escherichia coli LT enterotoxin genes. Gene (1989) 0.88

Antibody response to Campylobacter coli in children during intestinal infection and carriage. J Clin Microbiol (1988) 0.87

Roles of leukotriene B4, prostaglandin E2, and cyclic AMP in Campylobacter jejuni-induced intestinal fluid secretion. Infect Immun (1993) 0.86

Production of enterotoxin and cytotoxin in Campylobacter jejuni strains isolated in Costa Rica. J Med Microbiol (1992) 0.85

Isolation and partial characterization of the Campylobacter rectus cytotoxin. Microb Pathog (1993) 0.83

Cytotoxic activity on Chinese hamster ovary cells in culture filtrates of Campylobacter jejuni/coli. Lancet (1985) 0.83

Adherence, enterotoxigenicity, invasiveness and serogroups in Campylobacter jejuni and Campylobacter coli strains from adult humans with acute enterocolitis. APMIS (1990) 0.82

Enterotoxin production and serogroups of Campylobacter jejuni and Campylobacter coli from patients with diarrhea and from healthy laying hens. J Clin Microbiol (1989) 0.82

Toxins that inhibit host protein synthesis. Methods Enzymol (1994) 0.81

Partial purification and characterization of the enterotoxin produced by Campylobacter jejuni. Infect Immun (1990) 0.81

Effect of Campylobacter jejuni extracts and culture supernatants on cell culture. J Trop Med Hyg (1989) 0.81

A cytotonic, cholera toxin-like protein produced by Campylobacter jejuni. Comp Biochem Physiol B (1992) 0.81

Evidence for the presence of a receptor for the cytolethal distending toxin (CLDT) of Campylobacter jejuni on CHO and HeLa cell membranes and development of a receptor-based enzyme-linked immunosorbent assay for detection of CLDT. FEMS Microbiol Lett (1993) 0.80

Profiles of toxin production by thermophilic Campylobacter of animal origin. Vet Microbiol (1992) 0.80

Characteristics of cytotoxin produced by Campylobacter jejuni strains. Microbios (1994) 0.79